FR2270867B1 - - Google Patents

Info

Publication number
FR2270867B1
FR2270867B1 FR7515027A FR7515027A FR2270867B1 FR 2270867 B1 FR2270867 B1 FR 2270867B1 FR 7515027 A FR7515027 A FR 7515027A FR 7515027 A FR7515027 A FR 7515027A FR 2270867 B1 FR2270867 B1 FR 2270867B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7515027A
Other versions
FR2270867A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2270867A1 publication Critical patent/FR2270867A1/fr
Application granted granted Critical
Publication of FR2270867B1 publication Critical patent/FR2270867B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR7515027A 1974-05-14 1975-05-14 Expired FR2270867B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2423389A DE2423389A1 (de) 1974-05-14 1974-05-14 Arzneimittel mit psychotroper wirkung und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2270867A1 FR2270867A1 (fr) 1975-12-12
FR2270867B1 true FR2270867B1 (fr) 1978-08-04

Family

ID=5915522

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7515027A Expired FR2270867B1 (fr) 1974-05-14 1975-05-14

Country Status (11)

Country Link
US (1) US4053588A (fr)
JP (1) JPS50157361A (fr)
BE (1) BE829058A (fr)
CA (1) CA1067410A (fr)
DE (1) DE2423389A1 (fr)
DK (1) DK207575A (fr)
FR (1) FR2270867B1 (fr)
GB (1) GB1503680A (fr)
IE (1) IE41055B1 (fr)
LU (1) LU72449A1 (fr)
NL (1) NL7505479A (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1492640A (en) * 1975-07-08 1977-11-23 Ucb Sa L-pyroglutamyl-l-prolinamide
EP0257084B1 (fr) * 1986-02-28 1990-12-27 Hafslund Nycomed AS Utilisation d'un dipeptide à effet régulateur de la croissance cellulaire pour la préparation d'un médicament
IT1244548B (it) * 1991-02-06 1994-07-15 Poli Ind Chimica Spa Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
MXPA06001674A (es) 2003-08-12 2006-05-12 3M Innovative Properties Co Compuestos que contienen imidazo hidroxilamina-sustituidos.
EP1658076B1 (fr) 2003-08-27 2013-03-06 3M Innovative Properties Company Imidazoquinolines substituees par aryloxy et arylalkyleneoxy
EP1660026A4 (fr) 2003-09-05 2008-07-16 3M Innovative Properties Co Traitement pour le lymphome a cellules b cd5+
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AU2004278014B2 (en) 2003-10-03 2011-04-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
CN1906192A (zh) 2003-11-14 2007-01-31 3M创新有限公司 羟胺取代的咪唑环化合物
EP1685129A4 (fr) 2003-11-14 2008-10-22 3M Innovative Properties Co Composes d'un anneau d'imidazo substitues par oxime
AR046781A1 (es) 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
WO2005066170A1 (fr) 2003-12-29 2005-07-21 3M Innovative Properties Company Imidazoquinolines a substitution arylalcenyle et arylalkynyle
CA2551399A1 (fr) 2003-12-30 2005-07-21 3M Innovative Properties Company Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle
WO2005094531A2 (fr) 2004-03-24 2005-10-13 3M Innovative Properties Company Imidazopyridines, imidazoquinolines, et imidazonaphthyridines a substitution amide
WO2005123080A2 (fr) 2004-06-15 2005-12-29 3M Innovative Properties Company Imidazoquinolines et imidazonaphthyridines substituees par un heterocyclyle contenant un azote
WO2006009826A1 (fr) 2004-06-18 2006-01-26 3M Innovative Properties Company Thiazoloquinolines et thiazolonaphtyridines substitues par aryloxy et arylalkyleneoxy
WO2006065280A2 (fr) 2004-06-18 2006-06-22 3M Innovative Properties Company Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole
WO2006038923A2 (fr) 2004-06-18 2006-04-13 3M Innovative Properties Company Imidazonaphthyridines substituees par aryle
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
EP1831221B1 (fr) 2004-12-30 2012-08-08 3M Innovative Properties Company Composes chiraux 1,2 imidazo 4,5-c substitues a noyau fusionne
US20080119508A1 (en) * 2004-12-30 2008-05-22 3M Innovative Properties Company Multi-Route Administration Of Immune Response Modifier Compounds
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
AU2006213746A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
US7943636B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
JP2008535832A (ja) 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ，インコーポレイテッド ピラゾロピリジン−１，４−ジアミン、およびそのアナログ
WO2008008432A2 (fr) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants
DE102014110783A1 (de) * 2014-07-30 2016-02-04 Eberhard Karls Universität Tübingen Medizinische Fakultät Zusammensetzung zur Modulation der Aktivität von Nicht-Strukturproteinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE63496C (de) * B. A. DOBSON in Bolton, Grafsch. Lancaster, England, und E. APPENZELLER in Alost, Belgien Krempel mit Verringerung der Geschwindigkeit des Abnehmers beim Zerreifsen des Bandes
US3002978A (en) * 1958-05-06 1961-10-03 Bocher Gustave Marie Joseph Glyceryl pyrrolidone carboxylates
FR2207707A1 (en) * 1972-11-27 1974-06-21 Fabre Sa Pierre 2-Pyrrolidone-5-carboxylic acid esters and amides - with sedative and hypnotic activity

Also Published As

Publication number Publication date
LU72449A1 (fr) 1977-02-09
US4053588A (en) 1977-10-11
IE41055L (en) 1975-11-14
NL7505479A (nl) 1975-11-18
JPS50157361A (fr) 1975-12-19
DK207575A (da) 1975-11-15
FR2270867A1 (fr) 1975-12-12
CA1067410A (fr) 1979-12-04
IE41055B1 (en) 1979-10-10
GB1503680A (en) 1978-03-15
DE2423389A1 (de) 1975-12-04
BE829058A (fr) 1975-11-14

Similar Documents

Publication Publication Date Title
FR2270867B1 (fr)
FR2276484B3 (fr)
JPS50105287A (fr)
JPS50108222A (fr)
FR2257859A1 (fr)
JPS50131810A (fr)
JPS50100861A (fr)
JPS50132102U (fr)
JPS50122695U (fr)
JPS50113231U (fr)
CH579822A5 (fr)
CH604629A5 (fr)
CH573074A5 (fr)
CH568428B5 (fr)
CH567956A5 (fr)
CH567395A5 (fr)
CH566121A5 (fr)
CH564999A5 (fr)
CH532175A4 (fr)
CH573995A5 (fr)
CH1666774A4 (fr)
CH579884A5 (fr)
CH576222A5 (fr)
CH574074A5 (fr)
CH1378974A4 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse